Home » Localization » Deploying ePRO in Challenging Geographic Locations, Languages, and Cultures

Deploying ePRO in Challenging Geographic Locations, Languages, and Cultures

March 23, 2015

This webinar covers the various technical, logistical, cultural, linguistic, and regulatory challenges that may arise when deploying ePRO in certain geographic locations and ways to overcome them. We also review last month's survey results. Our guest presenter is Kristina Ernberg.

3:13

Translations and eConsent

When designing an informed consent, it's extremely important to consider the participants using it. Specifically, the consent should be created in a language that its primary audience will understand.

Watch Video

1:01:30

Translation of eCOA in Global Studies: Challenges and Solutions

For global clinical trials, eCOA instruments must be translated and then validated. This webinar provides insight into the regulations, timelines, and best practices related to linguistic validation.

Watch Video

Managing ePRO Patient Compliance in Emerging Markets

Brought to your by CRF Health and the TrialMax eCOA Solution - visit www.crfhealth.com for more information

Read

42:33

Overcoming Logistical Challenges in Global Clinical Trials

Deploying eCOA in a global clinical study requires a reliable supply chain, as well as an understanding of trade protocols for individual countries as they relate to importation of electronic devices.

Watch Video

39:21

Tips for Successful Translation and Localization of ePRO Applications for Global Studies

Chris Clancy and John Hutchin discuss localization and translation in global clinical trials, provid-ing guidance on streamlining processes to stay ahead of study timelines. Recorded July 23, 2009.

Watch Video

50:10

The Importance of Web-Based, Real-Time Reports for Global ePRO Projects

Chris Clancy discusses the values and benefits of real-time reports to various clinical trial stake-holders. He demos a variety of reports and provides tips for using reports. Recorded August 20, 2009

Watch Video

29:24

Deployment to India/Japan and Other Challenging Places

Kristina Ernberg looks at clinical trial case studies from several countries to explore challenges specific to certain geographical areas and identify ways of overcoming them. Recorded April 16, 2009.

Watch Video

Return to Home

Deploying ePRO in Challenging Geographic Locations, Languages, and Cultures

Previous

Next

Deploying ePRO in Challenging Geographic Locations, Languages, and Cultures

Previous

Next

Other content in this Stream

When designing an informed consent, it's extremely important to consider the participants using it. Specifically, the consent should be created in a language that its primary audience will understand.

For global clinical trials, eCOA instruments must be translated and then validated. This webinar provides insight into the regulations, timelines, and best practices related to linguistic validation.

Brought to your by CRF Health and the TrialMax eCOA Solution - visit www.crfhealth.com for more information

Deploying eCOA in a global clinical study requires a reliable supply chain, as well as an understanding of trade protocols for individual countries as they relate to importation of electronic devices.

Chris Clancy and John Hutchin discuss localization and translation in global clinical trials, provid-ing guidance on streamlining processes to stay ahead of study timelines. Recorded July 23, 2009.

Chris Clancy discusses the values and benefits of real-time reports to various clinical trial stake-holders. He demos a variety of reports and provides tips for using reports. Recorded August 20, 2009

Kristina Ernberg looks at clinical trial case studies from several countries to explore challenges specific to certain geographical areas and identify ways of overcoming them. Recorded April 16, 2009.